Podcasts

Podcasts | Jul. 23, 2014

Treat-to-Target in Lupus

Treat-to-Target is a treatment approach that has been used successfully in other diseases, including rheumatoid arthritis and diabetes. An international group of lupus experts has developed a set of recommendations for using this principle in lupus.

Podcasts | Jul. 01, 2014

Embarazo en pacientes con Lupus Eritematoso Sistémico

La planificación familiar y el embarazo son dos áreas de la vida familiar que requieren consideraciones especiales cuando usted tiene lupus. Durante esta presentación, el Dr. Jorge Sánchez-Guerrero hablará sobre las recomendaciones para planificar un embarazo sano y seguro.

Podcasts | Jun. 26, 2014

Epigenetics in Lupus

Epigenetics is a field of science that examines factors which influence whether genes are turned on or off when cells are replicated, which can influence whether a person might develop a specific disease, such as lupus.

Podcasts | Apr. 29, 2014

Ask the Expert - Photosensitivity in Cutaneous Lupus

Ask the Experts: Dr. Victoria Werth discusses photosensitivity in cutaneous lupus.

Podcasts | Feb. 27, 2014

Ask the Expert - Cardiac Issues and Lupus

This month's Ask the Experts features Jim Oates, MD, and Monica Richey, MSN, ANP-bc/GNP in a two-part presentations on cardiac issues and lupus. Listen to their presentations now!

Podcasts | Feb. 12, 2014

Hydroxycloroquine May Help Prevent APS Pregnancy Complications

Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.

Podcasts | Jan. 03, 2014

Ask the Experts: Health Insurance Marketplace

Ask the Experts: Susan Gustafson, Health Insurance Specialist, Centers for Medicare & Medicaid Services discusses the Health Insurance Marketplace

Podcasts | Nov. 13, 2013

Biomarkers of Lupus Disease: Eliminating the Perplexities of Lupus Treatment Trials

Lupus Foundation of America medical director Dr. Joan Merrill discusses a recently completed a study that may help to improve the design for future lupus clinical trials and secure approval of new safe and more tolerable treatments for lupus.